That represents a premium of nearly 31 percent to Express Scripts’ Wednesday closing price. Express Scripts shares were up 18.6 percent at $87.10, while Cigna shares were down 4.25 percent at $186. The transaction is valued at $67 billion, including about $15 billion in Express Scripts’ debt, the company said. DEAL DETAILSAfter the deal closes, Cigna shareholders will own about 64 percent of the combined company and Express Scripts shareholders the rest. Cigna intends to fund the cash portion of the deal through a combination of cash on hand, Express Scripts debt and new debt issuance.

Source: Huffington Post March 08, 2018 12:33 UTC